early stage drug development
Corporate Leadership Challenges - Compassionate Use & Expanded Access
April 23 by Pharmaceuticals & Biotechnology Editor“If you only have a limited number of doses of an experimental medicine, what do you do with that? Do you make it available for expanded access or do you gain more data for your ultimate...